3Marsh B, White M, Morton N ,et al. Pharmacokinetic model driven infusion of propofol in children [J]. Br J Anaesth, 1991,67(1): 41-48.
4Shüttler J, Ihmsen H. Population pharmacokinetics of propofol: a muhicenter study [ J ]. Anesthesiology, 2000,92(3) : 727-738.
5Mielke LL,Entholzner EK, King M, et al. Preoperative acute hypervolemic hemodilution with hydroxyethylstarch : an altemative to acute normovolemic hemodilution [ J ]. Anesth Analg, 1997, 84( 1 ) : 26-30.
6Yu Y, Zhou Z, Xu J et al. Ketamine reduces NF-kappa B activation and TNF alpha production in rat mononuclear cells induced by lipopolysaccharide in vitro[J]. Ann Clin Lab Sci, 2002, 32(3): 292-298.
7Liu Z, Yu Y, Jiang Y et al. Growth hormone increases lung NF-kappa B activation and lung microvascular injury induced by lipopolysaccharide in rats[J]. Ann Clin Lab Sci, 2002, 32(2): 164-170.
8Roytblat L, Talmor D, Rachinsky M et al. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass[J]. Anesth Analg, 1998, 87(2): 266-271.
9Kawasaki T, Ogata M, Kawasaki C. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro[J]. Anesth Analg, 1999, 89(3): 665-669.
10Blackwell TS, Yull FE, Chen CL et al. Use of genetically altered mice to investigate the role of nuclear factor-kappa B activation and cytokine gene expression in sepsis-induced ARDS[J]. Chest, 1999, 116(Suppl 1): 73-74.
10Pessenbacher K,Gutmann A, Eggenreich U,et al. Two propo-fol formulations are equivalent in small children aged 1 month to3 years[ J]. Acta Anaesthesiol Scand,2002,46 ( 3 ) :257-263.
